Displaying 25 - 36 items out of 167 results
ILCN article
Pathology Researcher Keith Kerr Receives 2025 Heine H. Hansen Award
… who has made a significant contribution to lung cancer research and education internationally. Previous award … divide between pathology and medical oncolog … Pathology Researcher Keith Kerr Receives 2025 Heine H. Hansen Award …
ILCN article
Regulating Artificial Intelligence
… regulate the use of artificial intelligence in clinical research? How likely is it that AI could lead us to erroneous … data-driven tools. ILCN: Another potential use for AI in research could be evaluating disease burden. To what extent do … Singh: FDA recognizes the interest and potential for AI research tools to aid in disease evaluation, such as with …
ILCN article
Gender Disparity in Lung Cancer
… for gender-sensitive approaches in healthcare policy, research, and clinical practice. Neglecting this issue not … to healthcare women face. As healthcare providers and researchers, understanding historical themes and raising … for gender-sensitive approaches in healthcare policy, research, and clinical practice. … Gender Disparity in Lung …
ILCN article
A Surprising Career Advances Cancer Research: Margaret Foti, MD, PhD (hc)
… A Surprising Career Advances Cancer Research: Margaret Foti, MD, PhD (hc) …
ILCN article
Researchers Present Significant Trial Results During WCLC 2022
… coverage and stay tuned for part 2 in future editions. … Researchers Present Significant Trial Results During WCLC 2022 …
ILCN article
Cultural Context Largely Absent in Advanced Care Planning Research, Guidelines
… Cultural Context Largely Absent in Advanced Care Planning Research, Guidelines …
ILCN article
Translating Early Research to Adapt CAR T-Cell Therapy to Solid Tumors
… Translating Early Research to Adapt CAR T-Cell Therapy to Solid Tumors …
ILCN article
Targeted Therapy Plus Immune Checkpoint Inhibitors: Research Opportunities, But No Improvement in
Activity to Date
… Targeted Therapy Plus Immune Checkpoint Inhibitors: Research Opportunities, But No Improvement in Activity to Date …











